Myles Wolf

Myles Wolf

Director/Board Member at AKEBIA THERAPEUTICS, INC.

Net worth: 192 752 $ as of 30/06/2026

55 year
Consumer Services
Health Technology

Profile

Myles Wolf currently works at Weill Cornell Medicine, as Chairman-Medicine, World Kidney Fund - International Society of Nephrology, as Chairman-North American Region, Akebia Therapeutics, Inc., as Independent Director from 2020, and Duke University School of Medicine, as Professor.
Dr. Wolf received his undergraduate degree from The Johns Hopkins University, graduate degree from Harvard Medical School, and doctorate degree from The State University of New York.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
17/06/2026 169,081 ( 0.06% ) 192 752 $ 30/06/2026

Myles Wolf active positions

CompaniesPositionStart
AKEBIA THERAPEUTICS, INC. Director/Board Member 06/04/2020
Corporate Officer/Principal 01/01/2002
The International Society of Nephrology (Belgium)
Corporate Officer/Principal -
Corporate Officer/Principal -

Training of Myles Wolf

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

17

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

The International Society of Nephrology (Belgium)

Consumer Services